Management of <scp>CLL</scp> patients early in the <scp>COVID</scp>‐19 pandemic: An international survey of <scp>CLL</scp> expertsBrian Koffman, Mazyar Shadman, Brad Hedrick et al.|American Journal of Hematology|2020Cited by 21
Real-world (RW) use of fixed-duration (FD) ibrutinib+venetoclax (Ibr+Ven) in patients (pts) with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Pooled analysis of REALITY-worldwide (WW) and REALITY-2 prospective cohort studiesCatherine Thiéblemont, Paolo Ghia, Emmanuelle Tchernonog et al.|Blood|2025Cited by 0